Medpace Holdings, Inc. to Report First Quarter 2019 Financial Results on April 29, 2019
CINCINNATI--(BUSINESS WIRE)--Apr 8, 2019--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2019 financial results after the market close on Monday, April 29, 2019. The Company will host a conference call the following morning, Tuesday, April 30, 2019, at 8:30 a.m. ET to discuss these results.
To participate in the conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using the passcode 8067378.
To access the conference call via webcast, visit the “Investors” section of Medpace’s website at investor.medpace.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
A supplemental slide presentation will also be available at the “Investors” section of Medpace’s website prior to the start of the call.
A recording of the call will be available from 12:00 p.m. ET on Tuesday, April 30, 2019 until 12:00 p.m. ET on Tuesday, May 14, 2019. To hear this recording, dial 855-859-2056 (domestic) or 404-537-3406 (international) using the passcode 8067378.
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,100 people across 36 countries.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190408005716/en/
CONTACT: Media Contact:
Medpace Holdings, Inc.
KEYWORD: UNITED STATES NORTH AMERICA OHIO
INDUSTRY KEYWORD: SURGERY HEALTH BIOTECHNOLOGY CARDIOLOGY CLINICAL TRIALS HOSPITALS MEDICAL DEVICES ONCOLOGY PHARMACEUTICAL OTHER HEALTH RESEARCH FDA SCIENCE
SOURCE: Medpace Holdings, Inc.
Copyright Business Wire 2019.
PUB: 04/08/2019 04:05 PM/DISC: 04/08/2019 04:05 PM